Cempra Inc (NASDAQ:CEMP)
| 2.85 Delayed Data As of 3:59pm ET |  -0.10 / -3.39%Today’s Change | 2.55 Today|||52-Week Range 26.95 | +1.79% Year-to-Date |
Latest CEMP News | Press Releases
No recent news for Cempra Inc.
Today’s Trading
| Previous close | 2.95 |
| Today’s open | 2.90 |
| Day’s range | 2.75 - 2.95 |
| Volume | 575,014 |
| Average volume (3 months) | 756,101 |
| Market cap | $154.9M |
| Dividend yield | -- |
Data as of 3:59pm ET, 08/21/2017
Growth & Valuation
| Earnings growth (last year) | -11.96% |
| Earnings growth (this year) | +58.39% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -34.03% |
| P/E ratio | NM |
| Price/Sales | 7.82 |
| Price/Book | 0.84 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| OCXOncoCyte Corp | -0.20 | -4.04% |
| RDHLRedhill Biopharma Lt... | -0.13 | -1.45% |
| OVIDOvid Therapeutics In... | +0.27 | +4.25% |
| MNKDMannKind Corp | -0.05 | -3.42% |
Data as of 7:59pm ET, 08/21/2017
Financials
| Next reporting date | November 1, 2017 |
| EPS forecast (this quarter) | -$0.18 |
| Annual revenue (last year) | $18.0M |
| Annual profit (last year) | -$118.0M |
| Net profit margin | -654.76% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chief Executive Officer & Director David Zaccardelli |
Chief Financial Officer & Executive Vice President Mark W. Hahn |
Corporate headquarters Chapel Hill, North Carolina |
Forecasts
